Related Experiment Videos
Quinolone-associated tendonitis: a potential problem in COPD?
M W Butler1, J F Griffin, W R Quinlan
1Department of Respiratory Medicine, St Vincent's University Hospital, Dublin, Ireland.
Irish Journal of Medical Science
|July 18, 2002
Summary
Newer fluoroquinolones, like levofloxacin, are effective for respiratory infections but can cause tendinopathy. Patients with chronic obstructive pulmonary disease (COPD) require careful monitoring for this rare side effect.
Area of Science:
- Medical Research
- Pharmacology
- Pulmonology
Background:
- Fluoroquinolones offer broader coverage for respiratory infections, unlike older quinolones.
- Tendinopathy is a rare but serious side effect associated with fluoroquinolone use.
Observation:
- This study details two cases of levofloxacin-associated tendinopathy.
- The patients presented with severe chronic obstructive pulmonary disease (COPD).
Findings:
- Levofloxacin-induced tendinopathy may be more common than previously thought.
- COPD patients on fluoroquinolones may have additional risk factors like age, corticosteroid use, and renal impairment.
Implications:
- Vigilance for tendonitis signs is crucial in COPD patients treated with fluoroquinolones.
- Understanding risk factors can help prevent fluoroquinolone-associated tendinopathy.